Cargando…
Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by the infiltration of macrophages in the fibrotic region. Currently, no therapeutic strategies effectively control disease progression, and the 5‐year mortality of patients after diagnosis is unacceptably h...
Autores principales: | Mou, Yong, Wu, Guo‐Rao, Wang, Qi, Pan, Ting, Zhang, Lei, Xu, Yongjian, Xiong, Weining, Zhou, Qing, Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115697/ https://www.ncbi.nlm.nih.gov/pubmed/35600643 http://dx.doi.org/10.1002/btm2.10280 |
Ejemplares similares
-
Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis
por: Pan, Ting, et al.
Publicado: (2021) -
Targeted delivery of ZNF416 siRNA-loaded liposomes attenuates experimental pulmonary fibrosis
por: Cheng, Demin, et al.
Publicado: (2022) -
Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022) -
Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing
por: Vollmann, Elisabeth H., et al.
Publicado: (2017) -
Attenuation of fibrosis in vitro and in vivo with SPARC siRNA
por: Wang, Jiu-Cun, et al.
Publicado: (2010)